Your browser doesn't support javascript.
loading
General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited.
Thurtle, David R; Gordon, Emma M; Brierly, Robert D; Conway, Ciaran J; McLoughlin, John.
Afiliación
  • Thurtle DR; Academic Urology Group, Department of Surgery, University of Cambridge, UK and West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, UK.
  • Gordon EM; Department of Urology, West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, UK.
  • Brierly RD; Department of Urology, Ipswich Hospital NHS Trust, Ipswich, UK.
  • Conway CJ; General Practice Registrar, Severn Deanery, University of Bristol, Bristol, UK.
  • McLoughlin J; Department of Urology, West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, UK.
Prostate Int ; 6(2): 61-65, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29922634

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Prostate Int Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Prostate Int Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido